precancerous

(redirected from pre-neoplastic)
Also found in: Dictionary, Encyclopedia.

pre·can·cer·ous

(prē-kan'sĕr-ŭs),
Pertaining to any lesion that is interpreted as precancer.
Synonym(s): premalignant

precancerous

/pre·can·cer·ous/ (-kan´ser-us) pertaining to a pathologic process that tends to become malignant.

precancerous

(prē-kăn′sər-əs)
adj.
Of, relating to, or being a condition that typically precedes or develops into a cancer: a precancerous growth.

precancerous

[-kan′sərəs]
Etymology: L, prae + cancer, crab
pertaining to a stage of abnormal tissue growth that is likely to develop into a malignant tumor.

precancerous

adjective Referring to a lesion or process that has a high risk of becoming malignant with time.

pre·can·cer·ous

(prē-kan'sĕr-ŭs)
Pertaining to any lesion that is interpreted as precancer.
Synonym(s): premalignant.

precancerous

Any condition tending to proceed to cancer, to be associated with the development of cancer, or to carry a significant risk of CANCER.

pre·can·cer·ous

(prē-kan'sĕr-ŭs)
Pertaining to any lesion that is interpreted as precancer.
Synonym(s): premalignant.

precancerous,

adj a stage of abnormal tissue growth that is likely or predisposed to develop into a malignant tumor.
References in periodicals archive ?
The histomorphological distribution pattern of benign lesions comprising of non-neoplastic and pre-neoplastic (195 cases) was as follows (Table 2).
In present study, chronic cervicitis and CIN cases had lower reported cases than expected from the population in considering that neoplastic cases were almost equal to non- and pre-neoplastic cases (48% vs 52%) in a period of 20 months.
A total of 04 pre-neoplastic (Ductal Carcinoma In-Situ=DCIS), 104 cancer mastectomies with lymph node dissection and 104 control tissues were analyzed in the study.
In order to quantify immune cell densities (cells/ mm2) in pre-neoplastic (DCIS), neoplastic (IDC) and control tissues, College of American Pathologists (CAP) guidelines were used.
Our investigations into quantification of immune cells demonstrate increased infiltration of both myeloid and lymphoid cells in pre-neoplastic (DCIS) tissues compared to control as well as cancer tissues (Table-I).
However, and interestingly, increased immune cell infiltration is observed in pre-neoplastic tissues (DCIS) compared to all tumour sub-types.
In this study, we have investigated and quantified immune cells in pre-neoplastic (Ductal carcinoma in-situ=DCIS), neoplastic and control breast tissues.
In this study, we show increased myelocyte and lymphocyte infiltration in the pre-neoplastic tissues compared to cancer and control tissues.
Table-I: Lymphocytic and Myelocytic infiltration in Pre-neoplastic (DCIS), cancer (IDC) and control tissues.
Immune cell densities within pre-neoplastic (DCIS), cancer (IDC) and control breast tissues